Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motohiro Tamiya

Showing results (61-70 of 192) with videos related to

Pageof 20
Sort By:
Thoracic Cancer|January 15, 2016
Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in JapanKazuhiro Asami, Masaaki Kawahara, Tomonori Hirashima, et al.
Thoracic Cancer|November 11, 2024
Lorlatinib overcomes alectinib-induced hemolytic anemia in an ALK fusion positive non-small-cell lung cancer patient with severe tumor-associated liver failure: A case reportKei Kunimasa, Akito Miyazaki, Motohiro Tamiya, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2012
Prognostic factors in malignant pleural mesothelioma: a retrospective studyHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Oncotarget|November 10, 2018
Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients?Akito Hata, Nobuyuki Katakami, Reiko Kaji, et al.
Japanese Journal of Clinical Oncology|September 23, 2024
Phase II study of carboplatin plus weekly paclitaxel with bevacizumab for non-squamous, non-small cell lung cancer with idiopathic interstitial pneumonia (Hanshin Cancer Group IP002)Nobuyuki Katakami, Kazuma Nagata, Akiyoshi Nakakura, et al.
BMC Pulmonary Medicine|May 13, 2016
Radial endobronchial ultrasound with a guide sheath for diagnosis of peripheral cavitary lung lesions: a retrospective studyManabu Hayama, Norio Okamoto, Hidekazu Suzuki, et al.
Molecular and Clinical Oncology|March 21, 2014
Carboplatin plus paclitaxel in combination with bevacizumab for the treatment of adenocarcinoma with interstitial lung diseasesHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
European Journal of Clinical Pharmacology|February 11, 2023
Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort studySatoshi Tanizaki, Kinnosuke Matsumoto, Akihiro Tamiya, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related eventsKei Kunimasa, Harumi Nakamura, Kazuko Sakai, et al.
CJC Open|July 22, 2022
A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related MyocarditisTatsuya Nishikawa, Motohiro Tamiya, Keiko Ohta-Ogo, et al.
Pageof 20

Showing results (61-70 of 192) with videos related to

Sort By:
Pageof 20
Thoracic Cancer|January 15, 2016
Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in JapanKazuhiro Asami, Masaaki Kawahara, Tomonori Hirashima, et al.
Thoracic Cancer|November 11, 2024
Lorlatinib overcomes alectinib-induced hemolytic anemia in an ALK fusion positive non-small-cell lung cancer patient with severe tumor-associated liver failure: A case reportKei Kunimasa, Akito Miyazaki, Motohiro Tamiya, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2012
Prognostic factors in malignant pleural mesothelioma: a retrospective studyHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Oncotarget|November 10, 2018
Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients?Akito Hata, Nobuyuki Katakami, Reiko Kaji, et al.
Japanese Journal of Clinical Oncology|September 23, 2024
Phase II study of carboplatin plus weekly paclitaxel with bevacizumab for non-squamous, non-small cell lung cancer with idiopathic interstitial pneumonia (Hanshin Cancer Group IP002)Nobuyuki Katakami, Kazuma Nagata, Akiyoshi Nakakura, et al.
BMC Pulmonary Medicine|May 13, 2016
Radial endobronchial ultrasound with a guide sheath for diagnosis of peripheral cavitary lung lesions: a retrospective studyManabu Hayama, Norio Okamoto, Hidekazu Suzuki, et al.
Molecular and Clinical Oncology|March 21, 2014
Carboplatin plus paclitaxel in combination with bevacizumab for the treatment of adenocarcinoma with interstitial lung diseasesHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
European Journal of Clinical Pharmacology|February 11, 2023
Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort studySatoshi Tanizaki, Kinnosuke Matsumoto, Akihiro Tamiya, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related eventsKei Kunimasa, Harumi Nakamura, Kazuko Sakai, et al.
CJC Open|July 22, 2022
A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related MyocarditisTatsuya Nishikawa, Motohiro Tamiya, Keiko Ohta-Ogo, et al.
Pageof 20